Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2010

May 5, 2010

30071_dirs_2010-05-05_274474c1-aa4a-4a95-a5ee-fe0668c66c3c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-05-03

Reporting Person: QUINN MICHAEL A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-05-03 ResMed Common Stock M 32000 $26.10 Acquired 203000 Direct
2010-05-03 ResMed Common Stock S 32000 $68.50 Disposed 171000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-05-03 ResMed Common Stock Options $26.10 M 32000 Disposed 2010-07-07 ResMed Common Stock (32000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 3300 Indirect

Footnotes

F1: Represents first day options became exercisable.

F2: We previously reported an aggregated amount of derivative securities beneficially owned. We are now reporting only those derivative securities beneficially owned that are of the same class as those disposed of in this trade -- identified by the SEC to be those that have the same grant date and exercise price.